Abbott Laboratories earnings per share and revenue
On 15 oct 2025, ABT reported earnings of 1.30 USD per share (EPS) for Q3 25, missing the estimate of 1.31 USD, resulting in a -1.06% surprise. Revenue reached 11.37 mil millones, compared to an expected 11.52 mil millones, with a -1.30% difference. The market reacted with a -2.87% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 27 analysts forecast an EPS of 1.51 USD, with revenue projected to reach 11.92 mil millones USD, implying an increase of 16.15% EPS, and increase of 4.87% in Revenue from the last quarter.
Preguntas frecuentes
What were Abbott Laboratories's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Abbott Laboratories reported EPS of $1.30, missing estimates by -1.06%, and revenue of $11.37B, -1.3% below expectations.
How did the market react to Abbott Laboratories's Q3 2025 earnings?
The stock price moved down -2.87%, changed from $133.27 before the earnings release to $129.45 the day after.
When is Abbott Laboratories expected to report next?
The next earning report is scheduled for 20 ene 2026.
What are the forecasts for Abbott Laboratories's next earnings report?
Based on 27
analysts, Abbott Laboratories is expected to report EPS of $1.51 and revenue of $11.92B for Q4 2025.